ProPhase Labs, Inc. (“ProPhase” or the “Company”), a diversified life sciences and diagnostics company, today announced that its common stock has been approved and uplisted from the Pink Sheets to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback